Literature DB >> 31600550

Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS).

E Makrinou1, A W Drong2, G Christopoulos3, A Lerner4, I Chapa-Chorda4, T Karaderi5, S Lavery3, K Hardy4, C M Lindgren6, S Franks4.   

Abstract

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder amongst women of reproductive age, whose aetiology remains unclear. To improve our understanding of the molecular mechanisms underlying the disease, we conducted a genome-wide DNA methylation profiling in granulosa lutein cells collected from 16 women suffering from PCOS, in comparison to 16 healthy controls. Samples were collected by follicular aspiration during routine egg collection for IVF treatment. Study groups were matched for age and BMI, did not suffer from other disease and were not taking confounding medication. Comparing women with polycystic versus normal ovarian morphology, after correcting for multiple comparisons, we identified 106 differentially methylated CpG sites with p-values <5.8 × 10-8 that were associated with 88 genes, several of which are known to relate either to PCOS or to ovarian function. Replication and validation of the experiment was done using pyrosequencing to analyse six of the identified differentially methylated sites. Pathway analysis indicated potential disruption in canonical pathways and gene networks that are, amongst other, associated with cancer, cardiogenesis, Hedgehog signalling and immune response. In conclusion, these novel findings indicate that women with PCOS display epigenetic changes in ovarian granulosa cells that may be associated with the heterogeneity of the disorder. Crown
Copyright © 2019. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA methylation; EWAS; Metabolic syndrome; PCOS; Reproduction

Mesh:

Year:  2019        PMID: 31600550      PMCID: PMC7116598          DOI: 10.1016/j.mce.2019.110611

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  58 in total

Review 1.  Application of proteomics to the study of polycystic ovary syndrome.

Authors:  M Insenser; H F Escobar-Morreale
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 4.256

2.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

Authors:  Zi-Jiang Chen; Han Zhao; Lin He; Yuhua Shi; Yingying Qin; Yongyong Shi; Zhiqiang Li; Li You; Junli Zhao; Jiayin Liu; Xiaoyan Liang; Xiaoming Zhao; Junzhao Zhao; Yingpu Sun; Bo Zhang; Hong Jiang; Dongni Zhao; Yuehong Bian; Xuan Gao; Ling Geng; Yiran Li; Dongyi Zhu; Xiuqin Sun; Jin-E Xu; Cuifang Hao; Chun-E Ren; Yajie Zhang; Shiling Chen; Wei Zhang; Aijun Yang; Junhao Yan; Yuan Li; Jinlong Ma; Yueran Zhao
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

3.  Allelic skewing of DNA methylation is widespread across the genome.

Authors:  Leonard C Schalkwyk; Emma L Meaburn; Rebecca Smith; Emma L Dempster; Aaron R Jeffries; Matthew N Davies; Robert Plomin; Jonathan Mill
Journal:  Am J Hum Genet       Date:  2010-02-12       Impact factor: 11.025

4.  Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome.

Authors:  Tao Li; Han Zhao; Xiaoming Zhao; Bo Zhang; Linlin Cui; Yuhua Shi; Guangyu Li; Peng Wang; Zi-Jiang Chen
Journal:  J Med Genet       Date:  2012-04       Impact factor: 6.318

5.  Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome.

Authors:  Jaye Adams; Zhilin Liu; Yi Athena Ren; Wan-Song Wun; Wei Zhou; Shlomit Kenigsberg; Clifford Librach; Cecilia Valdes; William Gibbons; JoAnne Richards
Journal:  J Clin Endocrinol Metab       Date:  2016-05-26       Impact factor: 5.958

6.  Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.

Authors:  Stephen Franks; Lisa J Webber; Micaela Goh; Anne Valentine; Davinia M White; Gerard S Conway; Steven Wiltshire; Mark I McCarthy
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

7.  Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.

Authors:  Felix Day; Tugce Karaderi; Michelle R Jones; Cindy Meun; Chunyan He; Alex Drong; Peter Kraft; Nan Lin; Hongyan Huang; Linda Broer; Reedik Magi; Richa Saxena; Triin Laisk; Margrit Urbanek; M Geoffrey Hayes; Gudmar Thorleifsson; Juan Fernandez-Tajes; Anubha Mahajan; Benjamin H Mullin; Bronwyn G A Stuckey; Timothy D Spector; Scott G Wilson; Mark O Goodarzi; Lea Davis; Barbara Obermayer-Pietsch; André G Uitterlinden; Verneri Anttila; Benjamin M Neale; Marjo-Riitta Jarvelin; Bart Fauser; Irina Kowalska; Jenny A Visser; Marianne Andersen; Ken Ong; Elisabet Stener-Victorin; David Ehrmann; Richard S Legro; Andres Salumets; Mark I McCarthy; Laure Morin-Papunen; Unnur Thorsteinsdottir; Kari Stefansson; Unnur Styrkarsdottir; John R B Perry; Andrea Dunaif; Joop Laven; Steve Franks; Cecilia M Lindgren; Corrine K Welt
Journal:  PLoS Genet       Date:  2018-12-19       Impact factor: 6.020

8.  Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.

Authors:  Felix R Day; David A Hinds; Joyce Y Tung; Lisette Stolk; Unnur Styrkarsdottir; Richa Saxena; Andrew Bjonnes; Linda Broer; David B Dunger; Bjarni V Halldorsson; Debbie A Lawlor; Guillaume Laval; Iain Mathieson; Wendy L McCardle; Yvonne Louwers; Cindy Meun; Susan Ring; Robert A Scott; Patrick Sulem; André G Uitterlinden; Nicholas J Wareham; Unnur Thorsteinsdottir; Corrine Welt; Kari Stefansson; Joop S E Laven; Ken K Ong; John R B Perry
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

9.  Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.

Authors:  Xiu-Xia Wang; Jing-Zan Wei; Jiao Jiao; Shu-Yi Jiang; Da-Hai Yu; Da Li
Journal:  Oncotarget       Date:  2014-08-30

10.  PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome.

Authors:  Shaini Joseph; Ram Shankar Barai; Rasika Bhujbalrao; Susan Idicula-Thomas
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

View more
  11 in total

1.  Current concepts of polycystic ovary syndrome pathogenesis.

Authors:  Robert L Rosenfield
Journal:  Curr Opin Pediatr       Date:  2020-10       Impact factor: 2.856

Review 2.  Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS.

Authors:  Viktor V Smirnov; Narasimha M Beeraka; Dmitry Yu Butko; Vladimir N Nikolenko; Sergey A Bondarev; Evgeniy E Achkasov; Mikhail Y Sinelnikov; P R Hemanth Vikram
Journal:  Reprod Sci       Date:  2022-06-28       Impact factor: 2.924

3.  The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis.

Authors:  Gurhan Guney; Mine Islimye Taşkın; Nazli Sener; Ezgi Tolu; Yavuz Dodurga; Levent Elmas; Orkun Cetin; Cengiz Sarigul
Journal:  Reprod Biol Endocrinol       Date:  2022-06-29       Impact factor: 4.982

4.  Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process.

Authors:  Nour El Houda Mimouni; Isabel Paiva; Anne-Laure Barbotin; Fatima Ezzahra Timzoura; Damien Plassard; Stephanie Le Gras; Gaetan Ternier; Pascal Pigny; Sophie Catteau-Jonard; Virginie Simon; Vincent Prevot; Anne-Laurence Boutillier; Paolo Giacobini
Journal:  Cell Metab       Date:  2021-02-03       Impact factor: 27.287

5.  Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women.

Authors:  Adeline Divoux; Edina Erdos; Katie Whytock; Timothy F Osborne; Steven R Smith
Journal:  Cells       Date:  2022-03-01       Impact factor: 6.600

6.  Differential expression of microRNA in the serum of patients with polycystic ovary syndrome with insulin resistance.

Authors:  Yan Huo; Shuqing Ji; Hua Yang; Weifan Wu; Lijing Yu; Yajing Ren; Fang Wang
Journal:  Ann Transl Med       Date:  2022-07

Review 7.  Why are women with polycystic ovary syndrome obese?

Authors:  T M Barber
Journal:  Br Med Bull       Date:  2022-09-22       Impact factor: 5.841

8.  miR‑132 is upregulated in polycystic ovarian syndrome and inhibits granulosa cells viability by targeting Foxa1.

Authors:  Xiangrong Cui; Xuan Jing; Junfen Liu; Xingyu Bi; Xueqing Wu
Journal:  Mol Med Rep       Date:  2020-10-14       Impact factor: 2.952

Review 9.  In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond.

Authors:  Agata Wawrzkiewicz-Jałowiecka; Karolina Kowalczyk; Paulina Trybek; Tomasz Jarosz; Patrycja Radosz; Marcin Setlak; Paweł Madej
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

10.  Hedgehog signal disruption, gonadal dysgenesis and reproductive disorders: Is there a link to endocrine disrupting chemicals?

Authors:  Hanna K L Johansson; Terje Svingen
Journal:  Curr Res Toxicol       Date:  2020-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.